{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:50:15Z","timestamp":1777409415345,"version":"3.51.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271062"],"award-info":[{"award-number":["32271062"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["K125280101"],"award-info":[{"award-number":["K125280101"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-03874-1","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T05:04:39Z","timestamp":1770786279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment with perampanel alleviates depression-like behavior in mice via modulating GluN2B expression to improve excitatory synaptic transmission"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2937-3563","authenticated-orcid":false,"given":"Jin-Ming","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8001-2178","authenticated-orcid":false,"given":"Bin-Wu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuye","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangwei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3261-7059","authenticated-orcid":false,"given":"Xiaohui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5983-9665","authenticated-orcid":false,"given":"Weibin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1889-4255","authenticated-orcid":false,"given":"Xiong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"3874_CR1","unstructured":"The burden of mental disorders across the states of India: the Global Burden of Disease Study 1990\u20132017. Lancet Psychiatry, 2020. 7:148-61."},{"key":"3874_CR2","doi-asserted-by":"crossref","first-page":"e006303","DOI":"10.1136\/bmjgh-2021-006303","volume":"6","author":"TH Hoppen","year":"2021","unstructured":"Hoppen TH, Priebe S, Vetter I, Morina N. Global burden of post-traumatic stress disorder and major depression in countries affected by war between 1989 and 2019: a systematic review and meta-analysis. BMJ Glob Health. 2021;6:e006303.","journal-title":"BMJ Glob Health"},{"key":"3874_CR3","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","volume":"392","author":"GS Malhi","year":"2018","unstructured":"Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299\u2013312.","journal-title":"Lancet"},{"key":"3874_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","volume":"7","author":"O Berton","year":"2006","unstructured":"Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006;7:137\u201351.","journal-title":"Nat Rev Neurosci"},{"key":"3874_CR5","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1056\/NEJMra050730","volume":"353","author":"JJ Mann","year":"2005","unstructured":"Mann JJ. The medical management of depression. N Engl J Med. 2005;353:1819\u201334.","journal-title":"N Engl J Med"},{"key":"3874_CR6","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455:894\u2013902.","journal-title":"Nature"},{"key":"3874_CR7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nj7419-299a","volume":"490","author":"V Gewin","year":"2012","unstructured":"Gewin V. Mental health: under a cloud. Nature. 2012;490:299\u2013301.","journal-title":"Nature"},{"key":"3874_CR8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","volume":"178","author":"RS McIntyre","year":"2021","unstructured":"McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178:383\u201399.","journal-title":"Am J Psychiatry"},{"key":"3874_CR9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2217\/cer-2022-0149","volume":"11","author":"M Brendle","year":"2022","unstructured":"Brendle M, Ahuja S, Valle MD, Moore C, Thielking P, Malone DC, et al. Safety and effectiveness of intranasal esketamine for treatment-resistant depression: a real-world retrospective study. J Comp Eff Res. 2022;11:1323\u201336.","journal-title":"J Comp Eff Res"},{"key":"3874_CR10","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ijnp\/pyz039","volume":"22","author":"M Fedgchin","year":"2019","unstructured":"Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, et al. Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double-blind, active-controlled study (TRANSFORM-1). Int J Neuropsychopharmacol. 2019;22:616\u201330.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3874_CR11","doi-asserted-by":"crossref","first-page":"172547","DOI":"10.1016\/j.ejphar.2019.172547","volume":"860","author":"A Nowacka","year":"2019","unstructured":"Nowacka A, Borczyk M. Ketamine applications beyond anesthesia - a literature review. Eur J Pharmacol. 2019;860:172547.","journal-title":"Eur J Pharmacol"},{"key":"3874_CR12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2018.01.017","volume":"142","author":"I Ivan Ezquerra-Romano","year":"2018","unstructured":"Ivan Ezquerra-Romano I, Lawn W, Krupitsky E, Morgan CJA. Ketamine for the treatment of addiction: evidence and potential mechanisms. Neuropharmacology. 2018;142:72\u201382.","journal-title":"Neuropharmacology"},{"key":"3874_CR13","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2174\/1381612828666220510115209","volume":"28","author":"MR Var\u00ec","year":"2022","unstructured":"Var\u00ec MR, Ricci G, Cavallo M, Pichini S, Sirignano A, Graziano S. Ketamine: from prescription anaesthetic to a new psychoactive substance. Curr Pharm Des. 2022;28:1213\u201320.","journal-title":"Curr Pharm Des"},{"key":"3874_CR14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","volume":"23","author":"P Zanos","year":"2018","unstructured":"Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol Psychiatry. 2018;23:801\u201311.","journal-title":"Mol Psychiatry"},{"key":"3874_CR15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature. 2016;533:481\u20136.","journal-title":"Nature"},{"key":"3874_CR16","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature22084","volume":"546","author":"K Suzuki","year":"2017","unstructured":"Suzuki K, Nosyreva E, Hunt KW, Kavalali ET, Monteggia LM. Effects of a ketamine metabolite on synaptic NMDAR function. Nature. 2017;546:E1\u2013e3.","journal-title":"Nature"},{"key":"3874_CR17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1085\/jgp.201812032","volume":"150","author":"KB Hansen","year":"2018","unstructured":"Hansen KB, Yi F, Perszyk RE, Furukawa H, Wollmuth LP, Gibb AJ, et al. Structure, function, and allosteric modulation of NMDA receptors. Journal of General Physiology. 2018;150:1081\u2013105.","journal-title":"Journal of General Physiology"},{"key":"3874_CR18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/mp.2010.44","volume":"16","author":"R Bernard","year":"2011","unstructured":"Bernard R, Kerman IA, Thompson RC, Jones EG, Bunney WE, Barchas JD, et al. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry. 2011;16:634\u201346.","journal-title":"Mol Psychiatry"},{"key":"3874_CR19","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI130808","volume":"130","author":"DM Gerhard","year":"2020","unstructured":"Gerhard DM, Pothula S, Liu RJ, Wu M, Li XY, Girgenti MJ, et al. GABA interneurons are the cellular trigger for ketamine\u2019s rapid antidepressant actions. J Clin Invest. 2020;130:1336\u201349.","journal-title":"J Clin Invest"},{"key":"3874_CR20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.phrs.2012.12.006","volume":"70","author":"V Franco","year":"2013","unstructured":"Franco V, Crema F, Iudice A, Zaccara G, Grillo E. Novel treatment options for epilepsy: focus on perampanel. Pharmacol Res. 2013;70:35\u201340.","journal-title":"Pharmacol Res"},{"key":"3874_CR21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuint.2012.02.035","volume":"61","author":"L Ceolin","year":"2012","unstructured":"Ceolin L, Bortolotto ZA, Bannister N, Collingridge GL, Lodge D, Volianskis A. A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampus. Neurochem Int. 2012;61:517\u201322.","journal-title":"Neurochem Int"},{"key":"3874_CR22","doi-asserted-by":"publisher","unstructured":"Rogawski, MA and T Hanada, Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist. Acta Neurol Scand Suppl 2013:19-24. https:\/\/doi.org\/10.1111\/ane.12100.","DOI":"10.1111\/ane.12100"},{"key":"3874_CR23","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.2174\/0929867311320230002","volume":"20","author":"M Catena-Dell\u2019Osso","year":"2013","unstructured":"Catena-Dell\u2019Osso M, Caserta A, Baroni S, Nisita C, Marazziti D. The relationship between epilepsy and depression: an update. Curr Med Chem. 2013;20:2861\u20137.","journal-title":"Curr Med Chem"},{"key":"3874_CR24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbrc.2021.12.038","volume":"588","author":"T Wang","year":"2022","unstructured":"Wang T, Wang L, Li L, Ma L, Liu X. Effects of perampanel on cognitive behavior and GluR1 expression in immature mice of temporal lobe epilepsy. Biochem Biophys Res Commun. 2022;588:68\u201374.","journal-title":"Biochem Biophys Res Commun"},{"key":"3874_CR25","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3390\/ph17101265","volume":"17","author":"M Beaurain","year":"2024","unstructured":"Beaurain M, Salabert AS, Payoux P, Gras E, Talmont F. NMDA receptors: distribution, role, and insights into neuropsychiatric disorders. Pharmaceuticals (Basel). 2024;17:1265.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3874_CR26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopsych.2020.12.006","volume":"90","author":"R Shinohara","year":"2021","unstructured":"Shinohara R, Aghajanian GK, Abdallah CG. Neurobiology of the rapid-acting antidepressant effects of ketamine: impact and opportunities. Biol Psychiatry. 2021;90:85\u201395.","journal-title":"Biol Psychiatry"},{"key":"3874_CR27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.brainres.2016.04.020","volume":"1647","author":"KF Raab-Graham","year":"2016","unstructured":"Raab-Graham KF, Workman ER, Namjoshi S, Niere F. Pushing the threshold: How NMDAR antagonists induce homeostasis through protein synthesis to remedy depression. Brain Res. 2016;1647:94\u2013104.","journal-title":"Brain Res"},{"key":"3874_CR28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","volume":"14","author":"P Paoletti","year":"2013","unstructured":"Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nature Reviews Neuroscience. 2013;14:383\u2013400.","journal-title":"Nature Reviews Neuroscience"},{"key":"3874_CR29","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu R-J, Banasr M, Dwyer JM, Iwata M, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010;329:959\u201364.","journal-title":"Science"},{"key":"3874_CR30","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/s42255-023-00924-6","volume":"5","author":"WT Dong","year":"2023","unstructured":"Dong WT, Long LH, Deng Q, Liu D, Wang JL, Wang F, et al. Mitochondrial fission drives neuronal metabolic burden to promote stress susceptibility in male mice. Nat Metab. 2023;5:2220\u201336.","journal-title":"Nat Metab"},{"key":"3874_CR31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1146\/annurev.cellbio.23.090506.123516","volume":"23","author":"JD Shepherd","year":"2007","unstructured":"Shepherd JD, Huganir RL. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu. Rev. Cell Dev. Biol. 2007;23:613\u201343.","journal-title":"Annu. Rev. Cell Dev. Biol"},{"key":"3874_CR32","doi-asserted-by":"crossref","first-page":"28596","DOI":"10.1074\/jbc.R115.652750","volume":"290","author":"MP Lussier","year":"2015","unstructured":"Lussier MP, Sanz-Clemente A, Roche KW. Dynamic regulation of N-methyl-d-aspartate (NMDA) and \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by posttranslational modifications. Journal of Biological Chemistry. 2015;290:28596\u2013603.","journal-title":"Journal of Biological Chemistry"},{"key":"3874_CR33","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1023\/A:1007644128886","volume":"25","author":"AL Carvalho","year":"2000","unstructured":"Carvalho AL, Duarte CB, Carvalho AP. Regulation of AMPA receptors by phosphorylation. Neurochemical research. 2000;25:1245\u201355.","journal-title":"Neurochemical research"},{"key":"3874_CR34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/ijms25010111","volume":"25","author":"Y-Y Cao","year":"2023","unstructured":"Cao Y-Y, Wu L-L, Li X-N, Yuan Y-L, Zhao W-W, Qi J-X, et al. Molecular mechanisms of AMPA receptor trafficking in the nervous system. International Journal of Molecular Sciences. 2023;25:111.","journal-title":"International Journal of Molecular Sciences"},{"key":"3874_CR35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fnmol.2017.00347","volume":"10","author":"J Widagdo","year":"2017","unstructured":"Widagdo J, Guntupalli S, Jang SE, Anggono V. Regulation of AMPA receptor trafficking by protein ubiquitination. Frontiers in Molecular Neuroscience. 2017;10:347.","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"3874_CR36","doi-asserted-by":"crossref","first-page":"1364037","DOI":"10.3389\/fddev.2024.1364037","volume":"4","author":"M Grados","year":"2024","unstructured":"Grados M, Salehi M, Lotfi A, Dua S, Xie I. A selective review of inhibitors of protein kinase C gamma: a neuroplasticity-related common pathway for psychiatric illness. Frontiers in Drug Delivery. 2024;4:1364037.","journal-title":"Frontiers in Drug Delivery"},{"key":"3874_CR37","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0166-2236(02)02270-1","volume":"25","author":"I Song","year":"2002","unstructured":"Song I, Huganir RL. Regulation of AMPA receptors during synaptic plasticity. Trends in neurosciences. 2002;25:578\u201388.","journal-title":"Trends in neurosciences"},{"key":"3874_CR38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrn3312","volume":"13","author":"Z Gao","year":"2012","unstructured":"Gao Z, Van Beugen BJ, De Zeeuw CI. Distributed synergistic plasticity and cerebellar learning. Nature Reviews Neuroscience. 2012;13:619\u201335.","journal-title":"Nature Reviews Neuroscience"},{"key":"3874_CR39","doi-asserted-by":"crossref","first-page":"e1006634","DOI":"10.1371\/journal.pgen.1006634","volume":"13","author":"J Zhu","year":"2017","unstructured":"Zhu J, Lee KY, Jewett KA, Man H-Y, Chung HJ, Tsai N-P. Epilepsy-associated gene Nedd4-2 mediates neuronal activity and seizure susceptibility through AMPA receptors. PLoS genetics. 2017;13:e1006634.","journal-title":"PLoS genetics"},{"key":"3874_CR40","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.3390\/ijms23073882","volume":"23","author":"S Haouari","year":"2022","unstructured":"Haouari S, Vourc\u2019h P, Jeanne M, Marouillat S, Veyrat-Durebex C, Lanznaster D, et al. The roles of NEDD4 subfamily of HECT E3 ubiquitin ligases in neurodevelopment and neurodegeneration. International journal of molecular sciences. 2022;23:3882.","journal-title":"International journal of molecular sciences"},{"key":"3874_CR41","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.biocel.2012.12.006","volume":"45","author":"P Donovan","year":"2013","unstructured":"Donovan P, Poronnik P. Nedd4 and Nedd4-2: ubiquitin ligases at work in the neuron. The international journal of biochemistry & cell biology. 2013;45:706\u201310.","journal-title":"The international journal of biochemistry & cell biology"},{"key":"3874_CR42","doi-asserted-by":"crossref","first-page":"19535","DOI":"10.1073\/pnas.0608492103","volume":"103","author":"J-C B\u00e9\u00efque","year":"2006","unstructured":"B\u00e9\u00efque J-C, Lin D-T, Kang M-G, Aizawa H, Takamiya K, Huganir RL. Synapse-specific regulation of AMPA receptor function by PSD-95. Proceedings of the National Academy of Sciences. 2006;103:19535\u201340.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"3874_CR43","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1523\/JNEUROSCI.4733-03.2004","volume":"24","author":"I Ehrlich","year":"2004","unstructured":"Ehrlich I, Malinow R. Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity. Journal of Neuroscience. 2004;24:916\u201327.","journal-title":"Journal of Neuroscience"},{"key":"3874_CR44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nn.2249","volume":"12","author":"S Bhattacharyya","year":"2009","unstructured":"Bhattacharyya S, Biou V, Xu W, Schl\u00fcter O, Malenka RC. A critical role for PSD-95\/AKAP interactions in endocytosis of synaptic AMPA receptors. Nature neuroscience. 2009;12:172\u201381.","journal-title":"Nature neuroscience"},{"key":"3874_CR45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0166-2236(96)10031-X","volume":"19","author":"J Sanchez-Prieto","year":"1996","unstructured":"Sanchez-Prieto J, Budd DC, Herrero I, V\u00e1zquez E, Nicholls DG. Presynaptic receptors and the control of glutamate exocytosis. Trends in neurosciences. 1996;19:235\u20139.","journal-title":"Trends in neurosciences"},{"key":"3874_CR46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3389\/fncel.2014.00401","volume":"8","author":"TE Chater","year":"2014","unstructured":"Chater TE, Goda Y. The role of AMPA receptors in postsynaptic mechanisms of synaptic plasticity. Frontiers in cellular neuroscience. 2014;8:401.","journal-title":"Frontiers in cellular neuroscience"},{"key":"3874_CR47","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.ph.57.030195.003343","volume":"57","author":"J Garthwaite","year":"1995","unstructured":"Garthwaite J, Boulton C. Nitric oxide signaling in the central nervous system. Annual review of physiology. 1995;57:683\u2013706.","journal-title":"Annual review of physiology"},{"key":"3874_CR48","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0092-8674(00)81797-3","volume":"87","author":"O Arancio","year":"1996","unstructured":"Arancio O, Kiebler M, Lee CJ, Lev-Ram V, Tsien RY, Kandel ER, et al. Nitric oxide acts directly in the presynaptic neuron to produce long-term potentiationin cultured hippocampal neurons. Cell. 1996;87:1025\u201335.","journal-title":"Cell"},{"key":"3874_CR49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuron.2009.06.021","volume":"63","author":"WG Regehr","year":"2009","unstructured":"Regehr WG, Carey MR, Best AR. Activity-dependent regulation of synapses by retrograde messengers. Neuron. 2009;63:154\u201370.","journal-title":"Neuron"},{"key":"3874_CR50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12865","volume":"56","author":"PN Patsalos","year":"2015","unstructured":"Patsalos PN. The clinical pharmacology profile of the new antiepileptic drug perampanel: a novel noncompetitive AMPA receptor antagonist. Epilepsia. 2015;56:12\u201327.","journal-title":"Epilepsia"},{"key":"3874_CR51","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1517\/17425255.2015.1061504","volume":"11","author":"A Schulze-Bonhage","year":"2015","unstructured":"Schulze-Bonhage A. Perampanel for epilepsy with partial-onset seizures: a pharmacokinetic and pharmacodynamic evaluation. Expert Opinion on Drug Metabolism & Toxicology. 2015;11:1329\u201337.","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"3874_CR52","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41572-023-00454-1","volume":"9","author":"W Marx","year":"2023","unstructured":"Marx W, Penninx B, Solmi M, Furukawa TA, Firth J, Carvalho AF, et al. Major depressive disorder. Nat Rev Dis Primers. 2023;9:44.","journal-title":"Nat Rev Dis Primers"},{"key":"3874_CR53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharmthera.2009.02.010","volume":"123","author":"R Machado-Vieira","year":"2009","unstructured":"Machado-Vieira R, Salvadore G, Diazgranados N, Zarate CA Jr. Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther. 2009;123:143\u201350.","journal-title":"Pharmacol Ther"},{"key":"3874_CR54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/clpt.2011.244","volume":"91","author":"JW Murrough","year":"2012","unstructured":"Murrough JW. Ketamine as a novel antidepressant: from synapse to behavior. Clin Pharmacol Ther. 2012;91:303\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"3874_CR55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/2045125313507739","volume":"4","author":"C Caddy","year":"2014","unstructured":"Caddy C, Giaroli G, White TP, Shergill SS, Tracy DK. Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy. Ther Adv Psychopharmacol. 2014;4:75\u201399.","journal-title":"Ther Adv Psychopharmacol"},{"key":"3874_CR56","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1038\/sj.mp.4001014","volume":"7","author":"CA Stewart","year":"2002","unstructured":"Stewart CA, Reid IC. Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission. Mol Psychiatry. 2002;7:S15\u201322.","journal-title":"Mol Psychiatry"},{"key":"3874_CR57","doi-asserted-by":"crossref","first-page":"429","DOI":"10.9758\/cpn.22.1034","volume":"21","author":"J Kim","year":"2023","unstructured":"Kim J, Kim TE, Lee SH, Koo JW. The role of glutamate underlying treatment-resistant depression. Clin Psychopharmacol Neurosci. 2023;21:429\u201346.","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"3874_CR58","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","volume":"121","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Danbolt NC. Glutamate as a neurotransmitter in the healthy brain. J Neural Transm (Vienna). 2014;121:799\u2013817.","journal-title":"J Neural Transm (Vienna)"},{"key":"3874_CR59","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.3390\/ijms23115954","volume":"23","author":"RI Teleanu","year":"2022","unstructured":"Teleanu RI, Niculescu AG, Roza E, Vlad\u00e2cenco O, Grumezescu AM, Teleanu DM. Neurotransmitters\u2014key factors in neurological and neurodegenerative disorders of the central nervous system. International journal of molecular sciences. 2022;23:5954.","journal-title":"International journal of molecular sciences"},{"key":"3874_CR60","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2012.10.032","volume":"698","author":"A Mehta","year":"2013","unstructured":"Mehta A, Prabhakar M, Kumar P, Deshmukh R, Sharma PL. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol. 2013;698:6\u201318.","journal-title":"Eur J Pharmacol"},{"key":"3874_CR61","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s10495-010-0481-0","volume":"15","author":"Y Wang","year":"2010","unstructured":"Wang Y, Qin ZH. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis. 2010;15:1382\u2013402.","journal-title":"Apoptosis"},{"key":"3874_CR62","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0006-3223(00)00971-9","volume":"48","author":"RM Sapolsky","year":"2000","unstructured":"Sapolsky RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry. 2000;48:755\u201365.","journal-title":"Biol Psychiatry"},{"key":"3874_CR63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1034\/j.1399-5618.2002.01144.x","volume":"4","author":"AL Lee","year":"2002","unstructured":"Lee AL, Ogle WO, Sapolsky RM. Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord. 2002;4:117\u201328.","journal-title":"Bipolar Disord"},{"key":"3874_CR64","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00702-013-1130-x","volume":"121","author":"MJ Niciu","year":"2014","unstructured":"Niciu MJ, Ionescu DF, Richards EM, Zarate CA. Jr., Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder. J Neural Transm (Vienna). 2014;121:907\u201324.","journal-title":"J Neural Transm (Vienna)"},{"key":"3874_CR65","doi-asserted-by":"crossref","first-page":"e160016","DOI":"10.1172\/JCI160016","volume":"133","author":"J Fan","year":"2023","unstructured":"Fan J, Guo F, Mo R, Chen LY, Mo JW, Lu CL, et al. O-GlcNAc transferase in astrocytes modulates depression-related stress susceptibility through glutamatergic synaptic transmission. J Clin Invest. 2023;133:e160016.","journal-title":"J Clin Invest"},{"key":"3874_CR66","volume":"15","author":"F Guo","year":"2024","unstructured":"Guo F, Fan J, Liu JM, Kong PL, Ren J, Mo JW, et al. Astrocytic ALKBH5 in stress response contributes to depressive-like behaviors in mice. Nat Commun. 2024;15:4347.","journal-title":"Nat Commun"},{"key":"3874_CR67","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.7150\/thno.72144","volume":"12","author":"XJ Kuang","year":"2022","unstructured":"Kuang XJ, Zhang CY, Yan BY, Cai WZ, Lu CL, Xie LJ, et al. P2X2 receptors in pyramidal neurons are critical for regulating vulnerability to chronic stress. Theranostics. 2022;12:3703\u201318.","journal-title":"Theranostics"},{"key":"3874_CR68","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuroscience.2021.02.027","volume":"461","author":"V Rodriguez-Chavez","year":"2021","unstructured":"Rodriguez-Chavez V, Moran J, Molina-Salinas G, Zepeda Ruiz WA, Rodriguez MC, Picazo O, et al. Participation of Glutamatergic Ionotropic Receptors in Excitotoxicity: The Neuroprotective Role of Prolactin. Neuroscience. 2021;461:180\u201393.","journal-title":"Neuroscience"},{"key":"3874_CR69","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ana.410440514","volume":"44","author":"M Urushitani","year":"1998","unstructured":"Urushitani M, Shimohama S, Kihara T, Sawada H, Akaike A, Ibi M, et al. Mechanism of selective motor neuronal death after exposure of spinal cord to glutamate: involvement of glutamate-induced nitric oxide in motor neuron toxicity and nonmotor neuron protection. Ann Neurol. 1998;44:796\u2013807.","journal-title":"Ann Neurol"},{"key":"3874_CR70","doi-asserted-by":"crossref","first-page":"1113081","DOI":"10.3389\/fnmol.2023.1113081","volume":"16","author":"G Fan","year":"2023","unstructured":"Fan G, Liu M, Liu J, Huang Y. The initiator of neuroexcitotoxicity and ferroptosis in ischemic stroke: Glutamate accumulation. Front Mol Neurosci. 2023;16:1113081.","journal-title":"Front Mol Neurosci"},{"key":"3874_CR71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0006-8993(91)91606-2","volume":"561","author":"IZ Nussenzveig","year":"1991","unstructured":"Nussenzveig IZ, Sircar R, Wong ML, Frusciante MJ, Javitt DC, Zukin SR. Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists. Brain Res. 1991;561:285\u201391.","journal-title":"Brain Res"},{"key":"3874_CR72","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51:199\u2013214.","journal-title":"Arch Gen Psychiatry"},{"key":"3874_CR73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-004-1982-8","volume":"179","author":"JH Krystal","year":"2005","unstructured":"Krystal JH, Abi-Saab W, Perry E, D\u2019Souza DC, Liu N, Gueorguieva R, et al. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology (Berl). 2005;179:303\u20139.","journal-title":"Psychopharmacology (Berl)"},{"key":"3874_CR74","first-page":"6871089","volume":"2017","author":"W Liu","year":"2017","unstructured":"Liu W, Ge T, Leng Y, Pan Z, Fan J, Yang W, et al. The role of neural plasticity in depression: from hippocampus to prefrontal cortex. Neural Plast. 2017;2017:6871089.","journal-title":"Neural Plast"},{"key":"3874_CR75","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","volume":"63","author":"S Maeng","year":"2008","unstructured":"Maeng S, Zarate CA Jr., Du J, Schloesser RJ, McCammon J, Chen G, et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry. 2008;63:349\u201352.","journal-title":"Biol Psychiatry"},{"key":"3874_CR76","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","volume":"28","author":"SH Preskorn","year":"2008","unstructured":"Preskorn SH, Baker B, Kolluri S, Menniti FS, Krams M, Landen JW. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. J Clin Psychopharmacol. 2008;28:631\u20137.","journal-title":"J Clin Psychopharmacol"},{"key":"3874_CR77","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s43440-021-00232-4","volume":"73","author":"S Kohtala","year":"2021","unstructured":"Kohtala S. Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms. Pharmacol Rep. 2021;73:323\u201345.","journal-title":"Pharmacol Rep"},{"key":"3874_CR78","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-00897-0","volume":"10","author":"PR Shiroma","year":"2020","unstructured":"Shiroma PR, Thuras P, Wels J, Albott CS, Erbes C, Tye S, et al. A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression. Transl Psychiatry. 2020;10:206.","journal-title":"Transl Psychiatry"},{"key":"3874_CR79","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1017\/S0033291714001603","volume":"45","author":"A McGirr","year":"2015","unstructured":"McGirr A, Berlim MT, Bond DJ, Fleck MP, Yatham LN, Lam RW. A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. Psychol Med. 2015;45:693\u2013704.","journal-title":"Psychol Med"},{"key":"3874_CR80","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","volume":"170","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013;170:1134\u201342.","journal-title":"Am J Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03874-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03874-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03874-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:04:12Z","timestamp":1771592652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03874-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3874"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-03874-1","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}